Eversept Partners, LP Eledon Pharmaceuticals, Inc. Transaction History

Eversept Partners, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2023	BUY	$2.45 - $3.88 $21,261 - $33,670	8,678 Added 14.69%	67,743 $182,000
Q3 2022 Nov 14, 2022	BUY	$2.45 - $3.88 $21,261 - $33,670	8,678 Added 14.69%	67,743 $187,000
Q2 2022 Nov 08, 2023	SELL	$2.34 - $3.96 $128,566 - $217,574	-54,943 Reduced 48.19%	59,065 $144,000
Q2 2022 Aug 15, 2022	SELL	$2.34 - $3.96 $128,566 - $217,574	-54,943 Reduced 48.19%	59,065 $144,000
Q1 2022 Nov 08, 2023	BUY	$3.06 - $4.89 $348,864 - $557,499	114,008 New	114,008 $449,000
Q3 2021 Nov 08, 2023	BUY	$5.94 - $8.46 $677,207 - $964,507	114,008 New	114,008 $704,000
Q3 2021 Nov 15, 2021	BUY	$5.94 - $8.46 $677,207 - $964,507	114,008 New	114,008 $705,000

18.4M

Ticker ELDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,756,800
Market Cap $55M
Description
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.